MMP9 and non-small cell lung carcinoma: In the present work, we found that nobiletin significantly increased the expression level of P53 and inhibited the expression of MMP9 in A549 cells, suggesting that P53 and MMP9 may be downstream targets of nobiletin in regulating NSCLC.